Treatment with incretin modulators, GLP-1 analogs and dipeptidyl peptidase-4 inhibitors reduces weight gain, minimizes hypoglycemia, decreases inflammation and is cardioprotective. The gene discussed is GCG; the disease is Hypoglycemia.